Lv5
1020 积分 2024-02-02 加入
Phage display and other peptide display technologies
2个月前
已完结
Nanobody‐based heavy chain antibodies and chimeric antibodies
2个月前
已完结
Controlling the sound of light: photoswitching optoacoustic imaging
3个月前
已完结
Antibody-Drug Conjugates: A promising breakthrough in cancer therapy
4个月前
已完结
The journey of antibody-drug conjugates for revolutionizing cancer therapy: A review
4个月前
已完结
Drug Review and Approval Policies Based on Real-world Evidence in China and the United States: A Comparative Study
4个月前
已完结
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
4个月前
已完结
Iruplinalkib (WX-0593) versus crizotinib in ALK TKI-naïve locally advanced or metastatic ALK-positive non-small cell lung cancer: interim analysis of a randomized, open-label, phase III study (INSPIRE)
4个月前
已完结
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
4个月前
已完结
Adjuvant sintilimab effective in high-risk HCC
4个月前
已完结
皖公网安备34019202002308
